1. Mossmann, Dirk, Müller, Christoph, Park, Sujin, Heim, Markus H, Hall, Michael N. 2023. Arginine reprograms metabolism in liver cancer via RBM39. In Cell, 186, 5068-5083.e23. doi:10.1016/j.cell.2023.09.011. https://pubmed.ncbi.nlm.nih.gov/37804830/
2. Xu, Yuewei, Nijhuis, Anke, Keun, Hector C. 2021. RNA-binding motif protein 39 (RBM39): An emerging cancer target. In British journal of pharmacology, 179, 2795-2812. doi:10.1111/bph.15331. https://pubmed.ncbi.nlm.nih.gov/33238031/
3. Lu, Sydney X, De Neef, Emma, Thomas, James D, Abdel-Wahab, Omar, Bradley, Robert K. 2021. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. In Cell, 184, 4032-4047.e31. doi:10.1016/j.cell.2021.05.038. https://pubmed.ncbi.nlm.nih.gov/34171309/
4. Campagne, Sébastien, Jutzi, Daniel, Malard, Florian, Ruepp, Marc-David, Allain, Frédéric H-T. 2023. Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39. In Nature communications, 14, 5366. doi:10.1038/s41467-023-40254-5. https://pubmed.ncbi.nlm.nih.gov/37666821/
5. Quan, Yongjun, Wang, Mingdong, Zhang, Hong, Lu, Dan, Ping, Hao. 2024. Spatial transcriptomics identifies RBM39 as a gene associated with Gleason score progression in prostate cancer. In iScience, 27, 111351. doi:10.1016/j.isci.2024.111351. https://pubmed.ncbi.nlm.nih.gov/39650727/
6. Cui, Fangfang, Wang, Wenling, Zhuang, Chunbo, He, Dezhi, Wang, Pei. 2024. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma. In Translational cancer research, 13, 1606-1622. doi:10.21037/tcr-23-2252. https://pubmed.ncbi.nlm.nih.gov/38737697/
7. Wang, Eric, Lu, Sydney X, Pastore, Alessandro, Abdel-Wahab, Omar, Aifantis, Iannis. 2019. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia. In Cancer cell, 35, 369-384.e7. doi:10.1016/j.ccell.2019.01.010. https://pubmed.ncbi.nlm.nih.gov/30799057/
8. Zhou, Jin, Simon, Jeremy M, Liao, Chengheng, Brugarolas, James, Zhang, Qing. 2022. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. In Molecular cell, 82, 3030-3044.e8. doi:10.1016/j.molcel.2022.06.003. https://pubmed.ncbi.nlm.nih.gov/35764091/
9. Jin, Qi, Harris, Ethan, Myers, Jacquelyn A, Obeng, Esther A, Crispino, John D. . Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia. In Blood, 144, 2417-2431. doi:10.1182/blood.2024024281. https://pubmed.ncbi.nlm.nih.gov/39316649/
智鼠故事 
